R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 44.25 PLN 2.08% Market Closed
Market Cap: 1B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Relative Value

The Relative Value of one RVU stock under the Base Case scenario is 41.11 PLN. Compared to the current market price of 44.25 PLN, Ryvu Therapeutics SA is Overvalued by 7%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RVU Relative Value
Base Case
41.11 PLN
Overvaluation 7%
Relative Value
Price
R
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
10
Median 3Y
25.1
Median 5Y
50.9
Industry
4
Forward
6.2
vs History
vs Industry
Median 3Y
-12.8
Median 5Y
-12.8
Industry
32.2
Forward
-24.3
vs History
vs Industry
0
Median 3Y
-12.9
Median 5Y
-18.2
Industry
21.7
vs History
vs Industry
6
Median 3Y
-8.8
Median 5Y
-15.3
Industry
34.2
vs History
28
vs Industry
17
Median 3Y
5.3
Median 5Y
5.3
Industry
2.6
vs History
96
vs Industry
11
Median 3Y
20.7
Median 5Y
47
Industry
3.8
Forward
5.2
vs History
49
vs Industry
10
Median 3Y
26.6
Median 5Y
21.2
Industry
8.3
vs History
vs Industry
Median 3Y
-11.9
Median 5Y
-16.4
Industry
18.6
Forward
-22.7
vs History
vs Industry
Median 3Y
-10.7
Median 5Y
-13.4
Industry
23.2
Forward
-17.1
vs History
vs Industry
1
Median 3Y
-11.4
Median 5Y
-16.5
Industry
20.7
vs History
vs Industry
7
Median 3Y
-7.9
Median 5Y
-12.5
Industry
28.4
vs History
47
vs Industry
15
Median 3Y
6.6
Median 5Y
6.8
Industry
2.3

Multiples Across Competitors

RVU Competitors Multiples
Ryvu Therapeutics SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Ryvu Therapeutics SA
WSE:RVU
1B PLN 16.1 -9.8 -9.1 -8.2
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 461.9 4 943.2 1 559.9 3 324.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
196.3B USD 4.6 32 20.8 29.8
US
Danaher Corp
NYSE:DHR
170.3B USD 8 43.8 27.4 41.2
KR
Samsung Biologics Co Ltd
KRX:207940
66.5T KRW 15.8 64.6 34.7 49.7
CH
Lonza Group AG
SIX:LONN
37.6B CHF 5.6 65.6 44.4 44.4
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 27.2 21.4 24.7
US
IQVIA Holdings Inc
NYSE:IQV
36.7B USD 2.4 26.1 14.3 21.8
US
Mettler-Toledo International Inc
NYSE:MTD
26.4B USD 7 33.2 23.8 26.6
US
West Pharmaceutical Services Inc
NYSE:WST
23B USD 8 45.9 30.8 38.7
US
Illumina Inc
NASDAQ:ILMN
22.3B USD 5.1 -14.1 31.7 67.8

See Also

Discover More
Back to Top